| Literature DB >> 34970591 |
John-Patrik M Burkhard1,2, Roland Giger3, Markus B Huber1, Benoît Schaller2, Ayla Little1, Sherin Khalil2, Dominique Engel1, Lukas M Löffel1, Patrick Y Wuethrich1.
Abstract
Postoperative complications in head and neck surgery are well-known, but a predictive model to guide clinicians in free flap reconstructions has not been established. This retrospective single-center observational study assessed 131 patients who underwent ablative surgery and received free flap reconstruction. Primary endpoint was the occurrence of systemic complications (PSC). Secondary endpoint was the generation of a nomogram of complications according to the CDC classification. In the ordinal regression model, postoperative administration of furosemide [1.36 (0.63-2.11), p < 0.0001], blood loss [0.001 (0.0004-0.0020), p = 0.004], postoperative nadir hemoglobin [-0.03 (-0.07-0.01), p = 0.108], smoking [0.72 (0.02-1.44), p = 0.043], and type of flap reconstruction [1.01 (0.21-1.84), p = 0.014] as predictors. A nomogram with acceptable discrimination was proposed (Somer's delta: 0.52). Application of this nomogram in clinical practice could help identify potentially modifiable risk factors and thus reduce the incidence of postoperative complications in patients undergoing microvascular reconstruction of the head and neck.Entities:
Keywords: Clavien-Dindo classification; free flap; head and neck surgery; nomogram; systemic complications
Year: 2021 PMID: 34970591 PMCID: PMC8713067 DOI: 10.3389/fsurg.2021.771282
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Baseline and clinical variables.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||
|
|
|
|
|
| |||
| Age, median [IQR], y | 64.0 [55.0;72.0] | 61.0 [52.8;71.0] | 61.0 [55.2;70.5] | 0.496 | 61.0 [54.0;71.0] | 64.0 [58.0;72.0] | 0.164 |
| Sex | 0.025 | 1.000 | |||||
| Female | 7 (24.1%) | 27 (48.2%) | 12 (26.1%) | 33 (35.1%) | 13 (35.1%) | ||
| Male | 22 (75.9%) | 29 (51.8%) | 34 (73.9%) | 61 (64.9%) | 24 (64.9%) | ||
| Alcohol consumption | 13 (44.8%) | 19 (33.9%) | 25 (54.3%) | 0.116 | 40 (42.6%) | 17 (45.9%) | 0.875 |
| Tobacco consumption | 15 (51.7%) | 33 (58.9%) | 32 (69.6%) | 0.277 | 57 (60.6%) | 23 (62.2%) | 1.000 |
| Hypertension | 7 (24.1%) | 25 (44.6%) | 17 (37.0%) | 0.179 | 29 (30.9%) | 20 (54.1%) | 0.023 |
| CHD | 1 (3.45%) | 4 (7.14%) | 6 (13.0%) | 0.337 | 6 (6.38%) | 5 (13.5%) | 0.291 |
| Cardiac | 0 (0.00%) | 1 (1.79%) | 7 (15.2%) | 0.006 | 0 (0.00%) | 8 (21.6%) | <0.001 |
| COPD | 4 (13.8%) | 10 (17.9%) | 10 (21.7%) | 0.682 | 12 (12.8%) | 12 (32.4%) | 0.018 |
| CKD classification eGFR [mL/min] | 0.217 | 0.475 | |||||
| GFR>89 | 27 (93.1%) | 50 (89.3%) | 44 (95.7%) | 88 (93.6%) | 33 (89.2%) | ||
| GFR 60–89 | 1 (3.45%) | 5 (8.93%) | 0 (0.00%) | 4 (4.26%) | 2 (5.41%) | ||
| GFR 30–59 | 1 (3.45%) | 1 (1.79%) | 2 (4.35%) | 2 (2.13%) | 2 (5.41%) | ||
| Liver/GIT | 0.743 | 0.825 | |||||
| Healthy | 26 (89.7%) | 51 (91.1%) | 42 (91.3%) | 85 (90.4%) | 34 (91.9%) | ||
| Viral hepatitis | 2 (6.90%) | 3 (5.36%) | 1 (2.17%) | 5 (5.32%) | 1 (2.70%) | ||
| Alcohol-related hepatitis | 0 (0.00%) | 1 (1.79%) | 0 (0.00%) | 1 (1.06%) | 0 (0.00%) | ||
| Peptic ulcer | 1 (3.45%) | 1 (1.79%) | 3 (6.52%) | 3 (3.19%) | 2 (5.41%) | ||
| Diabetes | 3 (10.3%) | 4 (7.14%) | 6 (13.0%) | 0.607 | 6 (6.38%) | 7 (18.9%) | 0.048 |
CHD, coronary heart disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; GIT, gastrointestinal tract; IQR, interquartile range; min, minute; mL, milliliters; SD, standard deviation; y, year.
Summarizes arterial hypertension and CHD.
Intraoperative and postoperative variables.
|
|
| ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
| |||
| Type of reconstruction | 0.069 | 1.000 | |||||
| Non-osseous | 25 (86.2%) | 43 (76.8%) | 29 (63.0%) | 70 (74.5%) | 27 (73.0%) | ||
| Osseous | 4 (13.8%) | 13 (23.2%) | 17 (37.0%) | 24 (25.5%) | 10 (27.0%) | ||
| Duration of surgery [min] | 511 [450;564] | 570 [487;661] | 587 [536;677] | 0.002 | 560 [487;636] | 571 [495;650] | 0.745 |
| Intraop. iv. fluid [total in mL] | 1,400 [1,050;2,050] | 1,600 [1,250;2,300] | 2,175 [1,542;2,552] | 0.018 | 1,750 [1,278;2,388] | 1,800 [1,300;2,500] | 0.667 |
| Blood loss [total in mL] | 500 [300;600] | 600 [450;912] | 775 [500;1,150] | 0.003 | 600 [400;900] | 700 [400;1,150] | 0.359 |
| Postop. nadir Hb [g/L] | 99.0 (9.75) | 93.2 (9.51) | 91.9 (9.01) | 0.005 | 94.7 (9.56) | 92.4 (10.0) | 0.245 |
| Norepinephrine [total in μg] | 192 [0.00;857] | 232 [0.00;651] | 236 [0.00;922] | 0.944 | 180 [0.00;704] | 428 [104;997] | 0.058 |
| Dobutamine [total in mg] | 11.5 [0.00;37.0] | 18.0 [0.00;43.0] | 26.0 [0.00;44.5] | 0.812 | 24.0 [0.00;45.8] | 0.00 [0.00;32.9] | 0.272 |
| Diuretics | 5 (17.2%) | 18 (32.1%) | 28 (60.9%) | <0.001 | 28 (29.8%) | 23 (62.2%) | 0.001 |
| Charlson Comorbidity Index | 8.00 [4.00;9.00] | 7.00 [4.00;9.00] | 7.00 [5.00;9.00] | 0.703 | 7.00 [5.00;9.00] | 7.00 [4.00;9.00] | 0.705 |
| Postop. blood administration [total in mL] | 0.00 [0.00;0.00] | 275 [275;775] | 275 [0.00;719] | <0.001 | 275 [0.00;550] | 275 [0.00;550] | 0.957 |
g/L, grams per liter; Hb, hemoglobin; iv, intravenous; mcg, micrograms; mg, milligrams; min, minutes; mL, milliliters.
Logistic regression model summary for the outcome “Relevant Systemic Complications.”
|
|
|
| |
|---|---|---|---|
| Fluid overload/Diuretics | 3.29 | 1.39, 8.06 | 0.008 |
| Blood loss (total in mL) | 1.0009 | 1.00003, 1.002 | 0.046 |
| Age at Diagnosis (y) | 1.05 | 1.01, 1.10 | 0.034 |
| CCI | 0.83 | 0.69, 0.98 | 0.035 |
| COPD | 4.49 | 1.58, 13.5 | 0.006 |
CI, confidence interval; CCI, Charlson Comorbidity Index; COPD, chronic obstructive pulmonary disease; mL, milliliters; OR, odds ratio; y, year.
Figure 1Effect plots of the logistic regression model to predict the outcome “Relevant Systemic Complications.” Solid blue lines denote the mean predictions, and shaded blue bands or pink bars denote the 95% confidence interval. mL, milliliters.
Figure 2(A) Nomogram of the logistic regression model for predicting the outcome “Relevant Systemic Complications.” (B) Nomogram of the ordinal regression model for predicting the risk categories of the outcome “Clavien-Dindo classification grade.” g/L, grams per liter; Hb, hemoglobin; mL, milliliters.
Ordinal regression model summary with the outcome “Clavien-Dindo classification grade.”
|
|
|
| |
|---|---|---|---|
|
| |||
| No Complications | Minor Complications | −2.39 | −1.41, 6.25 | 0.227 |
| Minor Complications | Major Complications | −0.02 | −3.77, 3.82 | 0.991 |
|
| |||
| Type of free flap reconstruction [osseous] | 1.01 | 0.21, 1.84 | 0.014 |
| Fluid overload/Diuretics | 1.36 | 0.63, 2.11 | <0.001 |
| Blood loss [total in mL] | 0.001 | 0.0004, 0.0020 | 0.004 |
| Postop. nadir Hb [g/L] | −0.03 | −0.07, 0.01 | 0.108 |
| Tobacco consumption | 0.72 | 0.02,1.44 | 0.043 |
CI, confidence interval; g/L, grams per liter; Hb, hemoglobin; mL, milliliters; OR, odds ratio; y, year.
Figure 3Effect plots of the ordinal regression model for predicting the outcome “Clavien-Dindo classification grade” (CDC; minor CDC: I-II; major CDC: IIIa-V). g/L, grams per liter; Hb, hemoglobin; mL, milliliters.
Clavien-Dindo classification of surgical complications (9).
|
|
|
|---|---|
| I | Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, or radiological interventions. Permitted therapeutic regimens are drugs as antiemetics, antipyretics, analgesics, diuretics, electrolytes, and physiotherapy. The grade also includes wound infections opened at the bedside. |
| II | Requiring pharmacological treatment with drugs other than those permitted for grade I complications. Blood transfusions and total parental nutrition are also included. |
| III a/b | Requiring surgical, endoscopic, or radiological intervention without (a) / with (b) general anesthesia. |
| IV | Life-threatening complication (including complications of the central nervous system) that requires management in a high dependency, or intensive therapy unit. - Single organ dysfunction (including dialysis) - Multiorgan dysfunction |
| V | Death |